4646 Brockton Ave.
Riverside, CA 92506
Richard A. Bender, M.D., FACP, Medical Advisor is based in Southern California, and is a board-certified medical oncologist practicing medicine at The Oncology Institute of Hope and Innovation.
Dr. Bender spent over 30 years in clinical practice, the majority spent serving as the Medical Director for Oncology/Hematology for Kaiser Permanente in San Diego. In 2002, he transitioned to the diagnostic industry where he has been the Medical Director for Hematology / Oncology for Quest Diagnostics and the Chief Medical Officer for Agendia and Signal Genetics, both molecular diagnostics companies. He has extensive experience in assay development, marketing, FDA clearance and reimbursement, as well as CLIA certification. He has also been the principal or co-investigator on numerous Phase 1, 2 and 3 clinical trials. Dr. Bender is an author of over 80 peer-reviewed scientific articles and numerous book chapters and has been invited to speak all over the world as an expert in oncology diagnostics. He was recently selected by the FDA as a consultant for the Medical Devices Advisory Committee.
Dr. Bender received his medical degree from the UCLA School of Medicine and spent 6 years at the National Cancer Institute, NIH where he was both a Clinical Associate and Senior Investigator in the Medicine Branch. He continues to teach at UCLA and serves as an expert reviewer in oncology for the Medical Boards of California and Arizona.